138 related articles for article (PubMed ID: 2952686)
41. [Lymphocyte subpopulations and HLA-DR determinations in diseases of the inner ear and Bell's palsy].
Bumm P; Schlimok G
HNO; 1986 Dec; 34(12):525-7. PubMed ID: 2950069
[TBL] [Abstract][Full Text] [Related]
42. The cell population in the cutaneous infiltrate of mycosis fungoides: in situ using monoclonal antisera.
Holden CA; Morgan EW; MacDonald DM
Br J Dermatol; 1982 Apr; 106(4):385-92. PubMed ID: 6462163
[TBL] [Abstract][Full Text] [Related]
43. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
[TBL] [Abstract][Full Text] [Related]
44. T-helper cell lymphoma involving the lymph nodes and skin. A clinical, morphologic, and immunohistochemical analysis of five cases.
van den Oord JJ; De Wolf-Peeters C; Frizzera G; Desmet VJ; Tricot G; Thomas J; Marien K; Gatter KC; Mason DY
Cancer; 1985 Apr; 55(8):1714-21. PubMed ID: 2579720
[TBL] [Abstract][Full Text] [Related]
45. The immunopathology of sequential tumor biopsies in patients treated with interleukin-2. Correlation of response with T-cell infiltration and HLA-DR expression.
Cohen PJ; Lotze MT; Roberts JR; Rosenberg SA; Jaffe ES
Am J Pathol; 1987 Nov; 129(2):208-16. PubMed ID: 3499823
[TBL] [Abstract][Full Text] [Related]
46. Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.
Selby WS; Janossy G; Bofill M; Jewell DP
Gut; 1984 Jan; 25(1):32-40. PubMed ID: 6228498
[TBL] [Abstract][Full Text] [Related]
47. Presence of in vivo-activated T-cells expressing HLA-DR molecules and IL-2 receptors in peripheral blood of patients with nasopharyngeal carcinoma.
Lakhdar M; Ellouz R; Kammoun H; Ben H'Tira S; Khedhiri N; Kastally R; Fridman WH
Int J Cancer; 1987 Jun; 39(6):663-9. PubMed ID: 3034803
[TBL] [Abstract][Full Text] [Related]
48. [A study of the expression of class II antigen on uterine cervical cancer cells and cell lines].
Okamoto Y; Ueda M; Yamada T; Misaki O; Seiki Y; Tsurunaga T; Iwai E; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1819-25. PubMed ID: 2974857
[TBL] [Abstract][Full Text] [Related]
49. Application of immunoelectron microscopy for identification of T lymphocyte subsets and HLA DR antigen positive cells in tissue.
Dienes HP; Essling K; John HD
J Histochem Cytochem; 1984 May; 32(5):547-51. PubMed ID: 6232311
[TBL] [Abstract][Full Text] [Related]
50. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation.
Fischer A; Sterkers G; Charron D; Durandy A
Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748
[TBL] [Abstract][Full Text] [Related]
51. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression.
Bröcker EB; Zwadlo G; Holzmann B; Macher E; Sorg C
Int J Cancer; 1988 Apr; 41(4):562-7. PubMed ID: 3128489
[TBL] [Abstract][Full Text] [Related]
53. OKT4+ and OKT8+ cell subset values and HLA-DR phenotypes.
Caruso C; Cillari E; Palmeri P; Lio D; Salerno A
J Clin Lab Immunol; 1985 Feb; 16(2):91-2. PubMed ID: 3872943
[TBL] [Abstract][Full Text] [Related]
54. Emergence of activated lymphocytes in CD4 and CD8 subpopulations of multiple myeloma: correlation with the expansion of suppressor T-cells (CD8+ OKM1+) and ecto-5'nucleotidase deficiency.
Massaia M; Dianzani U; Pioppo P; Boccadoro M; Redoglia V; Omede P; Pileri A
J Clin Lab Immunol; 1988 Jun; 26(2):89-95. PubMed ID: 2848130
[TBL] [Abstract][Full Text] [Related]
55. Keratinocyte T6 antigen expression after PUVA therapy.
Dreno B; Milpied B; Stalder JF; Guillet G; Litoux P
Acta Derm Venereol; 1987; 67(5):406-10. PubMed ID: 2448991
[TBL] [Abstract][Full Text] [Related]
56. Immunohistologic studies in pityriasis rosea. Evidence for cellular immune reaction in the lesional epidermis.
Aiba S; Tagami H
Arch Dermatol; 1985 Jun; 121(6):761-5. PubMed ID: 3890762
[TBL] [Abstract][Full Text] [Related]
57. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
58. Immunopathologic study of skin lesions in dermatomyositis.
Hausmann G; Herrero C; Cid MC; Casademont J; Lecha M; Mascaró JM
J Am Acad Dermatol; 1991 Aug; 25(2 Pt 1):225-30. PubMed ID: 1918457
[TBL] [Abstract][Full Text] [Related]
59. 2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells.
Tsuchiya N; Mitamura T; Goto M; Moroi Y; Kinoshita M; Yokohari R; Miyamoto T
J Rheumatol; 1988 Jun; 15(6):946-51. PubMed ID: 3262161
[TBL] [Abstract][Full Text] [Related]
60. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
